Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
Completed
Lederle Laboratories
Phase 2
1969-12-31
To determine the efficacy and toxicity of the combination of mitoxantrone hydrochloride (
Novantrone ) and etoposide in the treatment of patients with HIV associated lymphomas.
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer
Completed
Loyola University
Phase 2
1991-02-01
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, carboplatin, and
mitoxantrone, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Giving chemotherapy with autologous bone marrow
transplant may allow the doctor to give higher doses of chemotherapy and kill more tumor
cells.
PURPOSE: This phase II trial is studying how well chemotherapy and autologous bone marrow
transplant work in treating patients with refractory or recurrent ovarian cancer.
Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
Unknown status
Leiden University Medical Center
Phase 2
1992-07-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving drugs in different combinations may kill more tumor cells.
PURPOSE: Randomized phase II trial to compare the effectiveness of cyclophosphamide,
methotrexate, and fluorouracil with mitoxantrone in treating older patients with recurrent or
metastatic breast cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
